MEA Microfluidics Market

MEA Microfluidics Market Size (2023 to 2028)

The size of the microfluidics market in the Middle East and Africa is estimated to register a healthy CAGR during the forecast period.

Microfluidics is the science of manipulating and controlling fluids in micrometric channels. Applications of microfluidics range from diagnostics to pharmaceutical research. Microfluidics is gaining acceptance in healthcare applications due to the growing demand for point-of-care testing (POCT) and in-vitro diagnostics.

Due to the high demand for faster, cheaper, and decentralized diagnostics and their increasing use in molecular diagnostics, the microfluidics market in the Middle East and Africa is expected to witness healthy growth during the forecast period.

Microfluidics help supports pharmaceutical research and in vitro diagnostics, which in turn oversee the development of pharmaceutical research and clinical trials for proteomic analysis, genomic analysis, cell testing, and drug delivery. The in-vitro diagnostics segment is a driving factor in point-of-care testing, clinical diagnostics, environmental testing, and industrial testing, thereby contributing to the market growth during the forecast period.

In-vitro diagnostics held the largest share of the microfluidics market due to the increasing demand for POCT due to the introduction of one-pass diagnostic techniques by large companies. In addition, POCT is expected to grow at a faster growth rate in the face of the increasing incidence of chronic and infectious diseases and emerging technologies in the field.

However, the lower adoption in emerging economies is holding back the market's growth, and the lack of awareness and funding has caused an obstacle to growth in the Middle East and Africa regions. In addition, the complex and lengthy regulatory approval process, the high cost of on-board instruments and microfluidic sensors, and the lack of visibility of microfluidic products are slowing the growth of this market to some extent.

Impact of COVID-19 on the MEA microfluidics market:

COVID-19 has created the need for patient-friendly diagnostic applications due to the great benefits of POCT, which has greatly contributed to the market's growth in 2020-2022.

Early detection of COVID-19 is essential to control and eradicate the virus. In addition, early detection can help reduce the number of hospital visits and help the healthcare industry save lives by treating patients with faster test results than with conventional testing procedures.

RT-PCR testing was in high demand in 2020-2022; PCR and RT-PCR were the most reliable medical technology today. The demand in this market will increase even after the COVID-19 crisis due to its great advantages.

This market research report on the MEA microfluidics market has been segmented and sub-segmented following categories.

By Product:

• Microfluidic devices
• Microfluidic components

By Industry:

• In-vitro diagnostics
• Pharmaceutical
• Medical devices
• Others

By Material:

• Polymer
• Glass
• Silicon
• Others

By Application:

• Lab-on-a-chip
• Organs-on-chips
• Continuous flow
• Optofluidics
• Acoustofluidics
• Electrophoresis

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Middle Eastern regions such as Saudi Arabia, United Arab Emirates, Egypt, and others have a higher share of microfluidics than African regions. As a result, South Africa is expected to have a good growth rate than North Africa during the forecast period.

UAE is expected to grow at a higher rate in the coming years. Most of the UAE can be attributed to supplemental insurance plans for the laboratory testing procedure, the incidence rate of various infectious diseases, sufficient reimbursements for medical devices, and the presence of well-structured distribution channels. In the region. Additionally, the region's growing preference for point-of-service (POC) testing is further driving the microfluidics market in the Middle East. In addition, the increasing demand for home care services and the increasing application of self-administered transdermal micro-needles would further stimulate the growth of the microfluidics market.

In addition, increasing the number of private and public hospitals and independent clinics in the region would further stimulate the microfluidic market in the region.

Regions of Africa are expected to have a slow rise due to a lack of awareness and insufficient funds for proper development in microfluidics.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the MEA microfluidics market profiled in this report are Parker-Hannifin Corporation, SMC Corporation, Idex Corporation, Fluigent SA, Dolomite Microfluidics, Aignep S.P.A., Camozzi Automation Spa Società Unipersonale, Elveflow, Cellix Ltd., Fortive Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Perkinelmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson And Company, Illumina, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation and Abbott Laboratories.